Cresco Labs (CRLBF) Gross Margin (2020 - 2026)

Cresco Labs (CRLBF) posted Gross Margin of 49.86% for Q1 2026, down 3.33% on a QoQ basis from 51.58% in Q4 2025, and up 242.0% year-over-year from 14.58% in Q1 2025.

Cresco Labs (CRLBF) Gross Margin (2020 - 2026) Analysis & Trends

Cresco Labs' Gross Margin history runs 7 years deep, the most recent figure standing at 49.86% for Q1 2026.

  • Quarterly Gross Margin rose 242.0% year-over-year to 49.86% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 50.11% (up 39.0% YoY) and the FY2025 annual result came in at 49.49%, down 83.0% from the prior year.
  • Gross Margin was 49.86% for Q1 2026 at Cresco Labs, down from 51.58% in the prior quarter.
  • Across five years, Gross Margin topped out at 51.97% in Q3 2024 and bottomed at 43.81% in Q2 2023.
  • A 5-year average of 48.83% and a median of 49.86% in 2026 frame the typical range for Gross Margin.
  • Annual changes were most pronounced in 2023 — Gross Margin tumbled 789 bps — and 2024, when it jumped 760 bps.
  • Cresco Labs' Gross Margin stood at 43.94% in 2022, then climbed by 16 bps to 51.08% in 2023, then slipped by 6 bps to 47.77% in 2024, then climbed by 8 bps to 51.58% in 2025, then decreased by 3 bps to 49.86% in 2026.
  • Business Quant data shows CRLBF's Gross Margin at 49.86% in Q1 2026, 51.58% in Q4 2025, and 48.12% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 49.52%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 71.66%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 62.93%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 82.93%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.97%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 98.31%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.26%
10 Cresco Labs 254.96 Mn 99.57 Mn 75.45 Mn 49.86%

Historic Data

Download Data
DateValue
Mar 31, 2026 49.86%
Dec 31, 2025 51.58%
Sep 30, 2025 48.12%
Jun 30, 2025 50.88%
Mar 31, 2025 47.44%
Dec 31, 2024 47.77%
Sep 30, 2024 51.97%
Jun 30, 2024 51.41%
Mar 31, 2024 50.03%
Dec 31, 2023 51.08%
Sep 30, 2023 49.14%
Jun 30, 2023 43.81%
Mar 31, 2023 44.22%
Dec 31, 2022 43.94%
Sep 30, 2022 47.09%
Jun 30, 2022 51.70%
Mar 31, 2022 50.08%
Dec 31, 2021 50.52%
Sep 30, 2021 50.27%
Jun 30, 2021 48.09%